Bibrocathol

This classification denotes an antimicrobial with the molecular formula C6Br4O2.Bi.HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0KJ20H1BLJ, chemically known as 4,5,6,7-tetrabrom-1,3,2-benzodioxabismol-2-ol but generally known as bibrocathol, which bears US NIH Compound Identifier 16683103. European Medicines Agency schedules Bibrocathol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05816MIG. The term BIBROCATHOL is an International Non-Proprietary Name. World Health Organization schedules bibrocathol in its Anatomical Therapeutic Chemical (ATC) Classification. BIBROCATHOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bibrocathol under HS 29081900 and SITC 51244. As of Q4 2014, BIBROCATHOL remains the US FDA Preferred Term for this commodity. Bibrocathol bears US NLM identifiers UMLS ID C0602838 and NCI Concept Code C74156. SMILES: [BI]1(OC2C(O1)C(BR)C(BR)C(BR)C2BR)[OH2].